Sangamo Therapeutics
SGMO
SGMO
208 hedge funds and large institutions have $1.09B invested in Sangamo Therapeutics in 2018 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 54 increasing their positions, 73 reducing their positions, and 17 closing their positions.
Holders
208
Holders Change
+38
Holders Change %
+22.35%
% of All Funds
4.77%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
57
Increased
54
Reduced
73
Closed
17
Calls
$18.4M
Puts
$29.3M
Net Calls
-$10.9M
Net Calls Change
-$20.6M
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$132M |
| 2 |
CS
2
Credit Suisse
Zurich,
Switzerland
|
$36.8M |
| 3 |
3
Morgan Stanley
New York
|
$23.6M |
| 4 |
4
UBS AM
Chicago,
Illinois
|
$11.8M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$86.2M |
